Welcome to the 6th RNAi-Based Therapeutics Summit!
R&D
The 6th RNAi-Based Therapeutics Summit is returning to Boston in January 2025 with fresh insights and perspectives.
Having developed 5 of the 6 RNAi medicines on the market, Alnylam is setting the example for siRNA therapeutics and their Senior Vice President is joining this leading forum to share a critical update to the community of 100+ RNAi leaders.
From brand-new data on microRNA therapeutic potential to groundbreaking research into RNAi for oncology, this is a must-attend meeting to have on your 2025 radar!
Curious? Download the official brochure here: https://ter.li/8n4mnk
Don’t forget you can save up to 20% off when you register with your colleagues!
